1. Academic Validation
  2. Discovery of 4-anilino-N-methylthieno[3,2-d]pyrimidines and 4-anilino-N-methylthieno[2,3-d]pyrimidines as potent apoptosis inducers

Discovery of 4-anilino-N-methylthieno[3,2-d]pyrimidines and 4-anilino-N-methylthieno[2,3-d]pyrimidines as potent apoptosis inducers

  • Bioorg Med Chem Lett. 2009 Jul 1;19(13):3536-40. doi: 10.1016/j.bmcl.2009.04.145.
William Kemnitzer 1 Nilantha Sirisoma Chris May Ben Tseng John Drewe Sui Xiong Cai
Affiliations

Affiliation

  • 1 EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, CA 92121, USA.
Abstract

We report the discovery of N-((benzo[d][1,3]dioxol-5-yl)methyl)-6-phenylthieno[3,2-d]pyrimidin-4-amine (2a) as an Apoptosis Inducer using our proprietary cell- and caspase-based ASAP HTS assay, and SAR study of HTS hit 2a which led to the discovery of 4-anilino-N-methylthieno[3,2-d]pyrimidines and 4-anilino-N-methylthieno[2,3-d]pyrimidines as potent Apoptosis inducers. Compounds 5d and 5e were the most potent with EC(50) values of 0.008 and 0.004microM in T47D human breast Cancer cells, respectively. Compound 5d was found to be highly active in the MX-1 breast Cancer model. Functionally, compounds 5d and 5e both induced Apoptosis through inhibition of tubulin polymerization.

Figures